source name	characteristics[organism]	characteristics[organism part]	characteristics[individual]	characteristics[cell type]	characteristics[ancestry category]	characteristics[age]	characteristics[sex]	characteristics[developmental stage]	characteristics[disease]	characteristics[depletion]	characteristics[biological replicate]	characteristics[sampling time]	assay name	Technology type	comment[data file]	comment[file uri]	comment[fraction identifier]	comment[fractionation method]	comment[label]	comment[technical replicate]	comment[cleavage agent details]	comment[cleavage agent details]	comment[MS2 mass analyzer]	comment[instrument]	comment[separation]	comment[modification parameter]	comment[modification parameters]	comment[dissociation method]	comment[collision energy]	comment[precursor mass tolerance]	comment[fragment mass tolerance]	factor value[organism part]
PXD038669-DDA-Sample-1	Homo sapiens	blood plasma	1	not applicable	not available	not available	not available	not available	normal	no depletion	1	not applicable	221027_60SPD_DDA_Quant_ND_Plasma_200ng_test_01	proteomic profiling by mass spectrometry	221027_60SPD_DDA_Quant_ND_Plasma_200ng_test_01.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD038669/221027_60SPD_DDA_Quant_ND_Plasma_200ng_test_01.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\!P)'	AC=MS:1000484; NT=Orbitrap 	AC=MS:1003094; NT=Orbitrap Exploris 375	AC=PRIDE:0000563;NT=Reversed-phase chromatography	not available	not available	AC=MS:1000422;NT=HCD	30 NCE	15 ppm	20 ppm	blood serum
PXD038669-DDA-Sample-2	Homo sapiens	blood plasma	1	not applicable	not available	not available	not available	not available	normal	no depletion	1	not applicable	221027_60SPD_DDA_Quant_ND_Plasma_200ng_test_02	proteomic profiling by mass spectrometry	221027_60SPD_DDA_Quant_ND_Plasma_200ng_test_02.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD038669/221027_60SPD_DDA_Quant_ND_Plasma_200ng_test_02.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\!P)'	AC=MS:1000484; NT=Orbitrap 	AC=MS:1003094; NT=Orbitrap Exploris 376	AC=PRIDE:0000563;NT=Reversed-phase chromatography	not available	not available	AC=MS:1000422;NT=HCD	30 NCE	15 ppm	20 ppm	blood serum
PXD038669-DDA-Sample-3	Homo sapiens	blood plasma	1	not applicable	not available	not available	not available	not available	normal	no depletion	1	not applicable	221027_60SPD_DDA_Quant_ND_Plasma_200ng_test_03	proteomic profiling by mass spectrometry	221027_60SPD_DDA_Quant_ND_Plasma_200ng_test_03.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD038669/221027_60SPD_DDA_Quant_ND_Plasma_200ng_test_03.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\!P)'	AC=MS:1000484; NT=Orbitrap 	AC=MS:1003094; NT=Orbitrap Exploris 377	AC=PRIDE:0000563;NT=Reversed-phase chromatography	not available	not available	AC=MS:1000422;NT=HCD	30 NCE	15 ppm	20 ppm	blood serum
PXD038669-DDA-Sample-4	Homo sapiens	blood plasma	1	not applicable	not available	not available	not available	not available	normal	no depletion	1	not applicable	221027_60SPD_DDA_Quant_ND_Plasma_200ng_test_04	proteomic profiling by mass spectrometry	221027_60SPD_DDA_Quant_ND_Plasma_200ng_test_04.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD038669/221027_60SPD_DDA_Quant_ND_Plasma_200ng_test_04.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\!P)'	AC=MS:1000484; NT=Orbitrap 	AC=MS:1003094; NT=Orbitrap Exploris 378	AC=PRIDE:0000563;NT=Reversed-phase chromatography	not available	not available	AC=MS:1000422;NT=HCD	30 NCE	15 ppm	20 ppm	blood serum
PXD038669-DDA-Sample-5	Homo sapiens	blood plasma	1	not applicable	not available	not available	not available	not available	normal	no depletion	1	not applicable	221027_60SPD_DDA_Quant_ND_Plasma_200ng_test_05	proteomic profiling by mass spectrometry	221027_60SPD_DDA_Quant_ND_Plasma_200ng_test_05.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD038669/221027_60SPD_DDA_Quant_ND_Plasma_200ng_test_05.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	5	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\!P)'	AC=MS:1000484; NT=Orbitrap 	AC=MS:1003094; NT=Orbitrap Exploris 379	AC=PRIDE:0000563;NT=Reversed-phase chromatography	not available	not available	AC=MS:1000422;NT=HCD	30 NCE	15 ppm	20 ppm	blood serum
PXD038669-DDA-Sample-6	Homo sapiens	blood plasma	1	not applicable	not available	not available	not available	not available	normal	no depletion	1	not applicable	221027_60SPD_DDA_Quant_ND_Plasma_200ng_test_06	proteomic profiling by mass spectrometry	221027_60SPD_DDA_Quant_ND_Plasma_200ng_test_06.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD038669/221027_60SPD_DDA_Quant_ND_Plasma_200ng_test_06.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	6	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\!P)'	AC=MS:1000484; NT=Orbitrap 	AC=MS:1003094; NT=Orbitrap Exploris 380	AC=PRIDE:0000563;NT=Reversed-phase chromatography	not available	not available	AC=MS:1000422;NT=HCD	30 NCE	15 ppm	20 ppm	blood serum
PXD038669-DDA-Sample-7	Homo sapiens	blood plasma	1	not applicable	not available	not available	not available	not available	normal	no depletion	1	not applicable	221027_60SPD_DDA_Quant_ND_Plasma_200ng_test_07	proteomic profiling by mass spectrometry	221027_60SPD_DDA_Quant_ND_Plasma_200ng_test_07.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD038669/221027_60SPD_DDA_Quant_ND_Plasma_200ng_test_07.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	7	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\!P)'	AC=MS:1000484; NT=Orbitrap 	AC=MS:1003094; NT=Orbitrap Exploris 381	AC=PRIDE:0000563;NT=Reversed-phase chromatography	not available	not available	AC=MS:1000422;NT=HCD	30 NCE	15 ppm	20 ppm	blood serum
PXD038669-DDA-Sample-8	Homo sapiens	blood plasma	1	not applicable	not available	not available	not available	not available	normal	no depletion	1	not applicable	221027_60SPD_DDA_Quant_ND_Plasma_200ng_test_08	proteomic profiling by mass spectrometry	221027_60SPD_DDA_Quant_ND_Plasma_200ng_test_08.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD038669/221027_60SPD_DDA_Quant_ND_Plasma_200ng_test_08.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	8	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\!P)'	AC=MS:1000484; NT=Orbitrap 	AC=MS:1003094; NT=Orbitrap Exploris 382	AC=PRIDE:0000563;NT=Reversed-phase chromatography	not available	not available	AC=MS:1000422;NT=HCD	30 NCE	15 ppm	20 ppm	blood serum
PXD038669-DDA-Sample-9	Homo sapiens	blood plasma	1	not applicable	not available	not available	not available	not available	normal	no depletion	1	not applicable	221027_60SPD_DDA_Quant_ND_Plasma_200ng_test_09	proteomic profiling by mass spectrometry	221027_60SPD_DDA_Quant_ND_Plasma_200ng_test_09.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD038669/221027_60SPD_DDA_Quant_ND_Plasma_200ng_test_09.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	9	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\!P)'	AC=MS:1000484; NT=Orbitrap 	AC=MS:1003094; NT=Orbitrap Exploris 383	AC=PRIDE:0000563;NT=Reversed-phase chromatography	not available	not available	AC=MS:1000422;NT=HCD	30 NCE	15 ppm	20 ppm	blood serum
